The Pennant Group (NASDAQ:PNTG) Updates FY 2025 Earnings Guidance

The Pennant Group (NASDAQ:PNTG) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 1.030-1.110 for the period, compared to the consensus estimate of 1.080. The company issued revenue guidance of $800.0 million-$865.0 million, compared to the consensus revenue estimate of $816.2 million.

The Pennant Group Trading Up 0.2 %

Shares of NASDAQ:PNTG traded up $0.04 during mid-day trading on Thursday, hitting $25.54. The stock had a trading volume of 263,140 shares, compared to its average volume of 189,519. The Pennant Group has a 12-month low of $16.37 and a 12-month high of $37.13. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.12 and a current ratio of 1.12. The company has a market cap of $877.25 million, a PE ratio of 37.56, a P/E/G ratio of 2.24 and a beta of 1.92. The company’s 50 day moving average is $26.72 and its 200-day moving average is $30.62.

The Pennant Group (NASDAQ:PNTG) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.18 earnings per share for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.06). The Pennant Group had a return on equity of 13.47% and a net margin of 3.24%. On average, sell-side analysts predict that The Pennant Group will post 0.75 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on PNTG. Wells Fargo & Company initiated coverage on The Pennant Group in a research report on Thursday, December 19th. They issued an “equal weight” rating and a $33.00 price target on the stock. Oppenheimer raised their target price on shares of The Pennant Group from $34.00 to $37.00 and gave the company an “outperform” rating in a research note on Friday, November 8th. Finally, Truist Financial dropped their price objective on shares of The Pennant Group from $38.00 to $32.00 and set a “hold” rating on the stock in a research report on Monday, January 6th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $36.00.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.